Serum CCN1 protein levels were higher in patients with NASH (369.8 ± 90.1 pg/ml) than in healthy controls (240.4 ± 42.1 pg/ml) (Fig. 1A). Here, CCN1 is linked to metabolic dysfunction-associated steatohepatitis.